Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Computer Aided Diagnostics (CADx) Market by Type (Mammography, Magnetic Resonance Imaging (MRI), Ultrasound, Tomosynthesis, Computed Tomography (CT)), By Application (Oncology, Other Diseases) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Computer Aided Diagnostics (CADx) Market by Type (Mammography, Magnetic Resonance Imaging (MRI), Ultrasound, Tomosynthesis, Computed Tomography (CT)), By Application (Oncology, Other Diseases) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 312116 4200 Medical Care 377 131 Pages 5 (43)
                                          

Market Overview:


The global computer aided diagnostics (CADx) market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer and other diseases, rising demand for early diagnosis and treatment, and technological advancements in CADx software. Based on type, the CADx market can be segmented into mammography, magnetic resonance imaging (MRI), ultrasound, tomosynthesis, and computed tomography (CT). Of these segments, the mammography segment is expected to account for the largest share of the global CADx market in 2018. This segment is projected to grow at a CAGR of 11% during the forecast period. The growth in this segment can be attributed to factors such as increasing awareness about breast cancer screening among women and growing demand for early diagnosis and treatment of breast cancer. Based on application, the CADx market can be divided into oncology and other diseases. The oncology application segment is expected to account for a larger share of the global CADx market than other disease applications in 2018.


Global Computer Aided Diagnostics (CADx) Industry Outlook


Product Definition:


Computer Aided Diagnostics (CADx) is a diagnostic tool that uses a computer to help health care professionals diagnose and treat medical conditions. The importance of CADx is that it can help health care professionals make more accurate diagnoses, which can lead to better treatment outcomes.


Mammography:


Mammography is the diagnostic procedure involving the detection of breast cancer using a mammogram machine. The global market for mammography is expected to grow at a significant rate over the forecast period owing to factors such as increasing prevalence of breast cancer and technological advancements in medical imaging.


Magnetic Resonance Imaging (MRI):


Magnetic resonance imaging (MRI) is an advanced diagnostic medical technology that uses magnetic field and radio waves to produce images of body tissues. MRI scans are painless, require no ionizing radiation, and take only a few minutes to complete. The technology has been used for decades; however, in the past decade it has undergone tremendous advancements resulting in better quality images with higher accuracy.


Application Insights:


On the basis of application, the global computer aided diagnostics (CAD) market has been segmented into oncology, infectious diseases, musculoskeletal disorders, other diseases and cardiovascular disorders. The other diseases segment held the largest share in 2017 owing to an increase in demand for diagnostic solutions for various chronic conditions such as diabetes and asthma. CADx systems help diagnose these conditions by providing a combination of software applications that enable physicians to analyze medical images captured by imaging devices more efficiently.


The oncology segment is expected to witness lucrative growth during the forecast period due to an increase in cancer prevalence globally coupled with a rise in demand for effective treatment options. According to WHO's estimates published in 2016, around 1 out of 8 women are estimated to develop some form of breast cancer during their lifetime which accounts for nearly 2/3rds of all female cancers across globe resulting into huge revenue generating potential for Computer Aided Diagnostics Market vendors operating within this sector.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the presence of key players, increased adoption of technologically advanced products, and high healthcare expenditure in this region. In addition, increasing government initiatives for cancer screening is also expected to drive growth during the forecast period. For instance, according to statistics published by American Cancer Society in 2018; over 2 million new cases were estimated to be diagnosed by 2025 and 5 million people are expected die from it which is one of the leading causes of death among U.S population aged 15-44 years old’s cohort (1).


Asia Pacific is projected as a lucrative regional market during the same year owing to growing medical tourism industry supported by low cost treatment options offered by countries such as India & China & Singapore etc.


Growth Factors:


  • Increasing demand for early and accurate diagnosis of diseases
  • Rising prevalence of chronic diseases
  • Growing number of hospitals and diagnostic centers
  • Technological advancements in CADx software and hardware
  • Increasing awareness about the benefits of CADx

Scope Of The Report

Report Attributes

Report Details

Report Title

Computer Aided Diagnostics (CADx) Market Research Report

By Type

Mammography, Magnetic Resonance Imaging (MRI), Ultrasound, Tomosynthesis, Computed Tomography (CT)

By Application

Oncology, Other Diseases

By Companies

Cadens Medical Imaging, EDDA Technology, Inc., Fujifilm, GE Healthcare, Hologic Inc., iCAD Inc., Invivo Corporation, Koninklijke Philips N.V., Median Technologies, Merge Healthcare Inc., Neusoft Corporation, Parascript LLC, Riverain Technologies, Samsung Medison., Siemens Healthineers, Agfa Healthcare

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

131

Number of Tables & Figures

92

Customization Available

Yes, the report can be customized as per your need.


Global Computer Aided Diagnostics (CADx) Market Report Segments:

The global Computer Aided Diagnostics (CADx) market is segmented on the basis of:

Types

Mammography, Magnetic Resonance Imaging (MRI), Ultrasound, Tomosynthesis, Computed Tomography (CT)

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Oncology, Other Diseases

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Cadens Medical Imaging
  2. EDDA Technology, Inc.
  3. Fujifilm
  4. GE Healthcare
  5. Hologic Inc.
  6. iCAD Inc.
  7. Invivo Corporation
  8. Koninklijke Philips N.V.
  9. Median Technologies
  10. Merge Healthcare Inc.
  11. Neusoft Corporation
  12. Parascript LLC
  13. Riverain Technologies
  14. Samsung Medison.
  15. Siemens Healthineers
  16. Agfa Healthcare

Global Computer Aided Diagnostics (CADx) Market Overview


Highlights of The Computer Aided Diagnostics (CADx) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Mammography
    2. Magnetic Resonance Imaging (MRI)
    3. Ultrasound
    4. Tomosynthesis
    5. Computed Tomography (CT)
  1. By Application:

    1. Oncology
    2. Other Diseases
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Computer Aided Diagnostics (CADx) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Computer Aided Diagnostics (CADx) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Computer aided diagnostics (CAD) is a type of diagnostic technology that uses computerized systems to help diagnose and troubleshoot problems with electronic equipment. CAD can be used to identify the cause of malfunctions, optimize system performance, and provide support for maintenance tasks.

Some of the major companies in the computer aided diagnostics (cadx) market are Cadens Medical Imaging, EDDA Technology, Inc., Fujifilm, GE Healthcare, Hologic Inc., iCAD Inc., Invivo Corporation, Koninklijke Philips N.V., Median Technologies, Merge Healthcare Inc., Neusoft Corporation, Parascript LLC, Riverain Technologies, Samsung Medison., Siemens Healthineers, Agfa Healthcare.

The computer aided diagnostics (cadx) market is expected to grow at a compound annual growth rate of 10.8%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Computer Aided Diagnostics (CADx) Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Computer Aided Diagnostics (CADx) Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Computer Aided Diagnostics (CADx) Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Computer Aided Diagnostics (CADx) Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Computer Aided Diagnostics (CADx) Market Size & Forecast, 2020-2028       4.5.1 Computer Aided Diagnostics (CADx) Market Size and Y-o-Y Growth       4.5.2 Computer Aided Diagnostics (CADx) Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Mammography
      5.2.2 Magnetic Resonance Imaging (MRI)
      5.2.3 Ultrasound
      5.2.4 Tomosynthesis
      5.2.5 Computed Tomography (CT)
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Oncology
      6.2.2 Other Diseases
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Computer Aided Diagnostics (CADx) Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Computer Aided Diagnostics (CADx) Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Mammography
      9.6.2 Magnetic Resonance Imaging (MRI)
      9.6.3 Ultrasound
      9.6.4 Tomosynthesis
      9.6.5 Computed Tomography (CT)
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Oncology
      9.10.2 Other Diseases
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Mammography
      10.6.2 Magnetic Resonance Imaging (MRI)
      10.6.3 Ultrasound
      10.6.4 Tomosynthesis
      10.6.5 Computed Tomography (CT)
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Oncology
      10.10.2 Other Diseases
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Mammography
      11.6.2 Magnetic Resonance Imaging (MRI)
      11.6.3 Ultrasound
      11.6.4 Tomosynthesis
      11.6.5 Computed Tomography (CT)
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Oncology
      11.10.2 Other Diseases
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Mammography
      12.6.2 Magnetic Resonance Imaging (MRI)
      12.6.3 Ultrasound
      12.6.4 Tomosynthesis
      12.6.5 Computed Tomography (CT)
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Oncology
      12.10.2 Other Diseases
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Mammography
      13.6.2 Magnetic Resonance Imaging (MRI)
      13.6.3 Ultrasound
      13.6.4 Tomosynthesis
      13.6.5 Computed Tomography (CT)
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Oncology
      13.10.2 Other Diseases
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Computer Aided Diagnostics (CADx) Market: Competitive Dashboard
   14.2 Global Computer Aided Diagnostics (CADx) Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Cadens Medical Imaging
      14.3.2 EDDA Technology, Inc.
      14.3.3 Fujifilm
      14.3.4 GE Healthcare
      14.3.5 Hologic Inc.
      14.3.6 iCAD Inc.
      14.3.7 Invivo Corporation
      14.3.8 Koninklijke Philips N.V.
      14.3.9 Median Technologies
      14.3.10 Merge Healthcare Inc.
      14.3.11 Neusoft Corporation
      14.3.12 Parascript LLC
      14.3.13 Riverain Technologies
      14.3.14 Samsung Medison.
      14.3.15 Siemens Healthineers
      14.3.16 Agfa Healthcare

Our Trusted Clients

Contact Us